- Active ETFs
- ARKK
ARK Innovation ETF
- ARKQ
ARK Autonomous Tech. & Robotics ETF
- ARKW
ARK Next Generation Internet ETF
- ARKG
ARK Genomic Revolution ETF
- ARKF
ARK Fintech Innovation ETF
- ARKX
ARK Space Exploration & Innovation ETF
Our ETFsFund Documents - ARKK
- Index ETFs
- PRNT
The 3D Printing ETF
- IZRL
ARK Israel Innovative Technology ETF
- Other Funds
- PRNT
Our ETFs
Fund Documents
ARKK
Aims for thematic multi-cap exposure to innovation across sectors. ARK believes the securities held in ARKK present the best risk-reward opportunities from ARK’s innovation-based themes.
Aims to capture long-term growth with low correlation of relative returns to traditional growth strategies and negative correlation to value strategies.
Offers a tool for diversification due to little overlap with traditional indices. It can be a complement to traditional value/growth strategies.
Combines top-down and bottom-up research in its portfolio management to identify innovative companies and convergence across markets.
Provides a lower cost alternative to mutual funds with true active management in an Exchange Traded Fund (ETF) that invests in rapidly moving themes.
- MANAGEMENT FEE0.75%
- DISTRIBUTION AND/OR SERVICE (12B-1) FEES0.75%
- OTHER EXPENSES0.75%
- TICKERARKK
- FUND AUM$8.9 Billion
- TYPEActive Equity ETF
- CUSIP00214Q 104
- PRIMARY EXCHANGENYSE ARCA
- INCEPTION DATE10/31/2014
- EXPENSE RATIO0.75%
- TYPICAL NUMBER OF HOLDINGS35-55
- WEIGHTED AVG. MARKET CAP.$76.3 Billion
- MEDIAN MARKET CAP.$5.9 Billion
- ADVISORARK Investment Management LLC
- SALES SERVICES Resolute Investment Distributors, Inc.
- FUND DISTRIBUTOR Foreside Fund Services, LLC
| ARKK | 1 Months | 3 Months | YTD | 1 Year | 3 Years | 5 Years | Since Inception |
| NAV | 26.28% | 29.18% | 83.72% | 115.18% | 41.49% | 39.20% | 30.97% |
| Market Price | 26.16% | 29.01% | 83.82% | 115.30% | 41.21% | 39.37% | 30.98% |
*Annualized
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. The Fund’s most recent month-end performance can be found in the fund material section. Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.
| Ticker | Name | Sector | Asset Class | Market Value | Weight (%) | Notional Value |
|---|---|---|---|---|---|---|
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 7.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 8.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 7.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 8.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 7.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 8.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 7.05% | $1,048,954,964 |
| TSLA | Crispr Therapeutics AG | Consumer Discretionary | Equity | $1,048,954,964 | 8.05% | $1,048,954,964 |
| Country |
Fund
% of Market Value
|
|---|---|
| United States |
100
|
| Germany |
90
|
| France |
80
|
| United States |
70
|
| IItaly |
60
|
| Russia |
50
|
| China |
40
|
| United States |
30
|
| Switzerland |
20
|
| United Kingdom |
10
|
Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK ETF before investing. This and other information are contained in the ARK ETFs' prospectuses, which may be obtained by clicking here. The prospectus should be read carefully before investing. An investment in an ARK ETF is subject to risks and you can lose money on your investment in an ARK ETF. There can be no assurance that the ARK ETFs will achieve their investment objectives. The ARK ETFs’ portfolios are more volatile than broad market averages. The ARK ETFs also have specific risks, which are described in the ARK ETFs' prospectuses.
- Premium:37
- NAV:19
- Discount:10
- Percent of Days ± 0.5% of NAV:100%
- Number of Days ± 0.5% of NAV:57
The Premium/Discount chart shows the difference between the daily market price of the Fund’s shares and the Fund’s net asset value (“NAV”). The daily market price is calculated using the mid-point between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund’s NAV is calculated (usually 4:00 pm Eastern time). The vertical axis of the chart shows the premium or discount of the Mid-Point price as a percentage of the NAV. The horizontal axis shows the number of trading days covered by the chart, and each bar in the chart demonstrates how many days the Fund traded within the given premium/discount range. The data presented in the chart and table above represent past performance and cannot be used to predict future results.
DISCLOSURE
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information are contained in the prospectus. Please read the prospectus carefully before investing.
The principal risks of investing in the ARKK include: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Health Care Sector Risk. The health care sector may be adversely affected by government regulations and government health care programs. Industrials Sector Risk. Companies in the industrials sector may be adversely affected by changes in government regulation, world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Cryptocurrency Risk. Cryptocurrency (notably, bitcoin), often referred to as ‘‘virtual currency’’ or ‘‘digital currency,’’ operates as a decentralized, peer-to-peer financial exchange and value storage that is used like money. The Fund may have exposure to bitcoin, a cryptocurrency, indirectly through an investment in the Bitcoin Investment Trust (‘‘GBTC’’), a privately offered, open-end investment vehicle. Cryptocurrency operates without central authority or banks and is not backed by any government. Even indirectly, cryptocurrencies may experience very high volatility and related investment vehicles like GBTC may be affected by such volatility. As a result of holding cryptocurrency, the Fund may also trade at a significant premium to NAV. Cryptocurrency is also not legal tender. Federal, state or foreign governments may restrict the use and exchange of cryptocurrency, and regulation in the U.S. is still developing. Cryptocurrency exchanges may stop operating or permanently shut down due to fraud, technical glitches, hackers or malware. Additional risks of investing in ARKK include foreign securities, market, management and non-diversification risks. Detailed information regarding the specific risks of ARKK can be found in the ETF’s prospectus.
Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security.
Award Disclosure
[1] Other Finalists “Active ETF of the Year” 2018: TrimTabs All Cap U.S. Free-Cash-Flow ETF (TTAC), WBI BullBear Yield 1000 ETF (WBIG), WisdomTree U.S. Quality Shareholder Yield Fund (QSY); | Methodology: Ranking Entity: Fund Intelligence; Length of the period: 12 Months; Criteria on which the ranking is based: The winners are comprised of the individuals and firms who have been nominated via the online submission process and through recommendations from market participants. Judges will use the submitted application material, as well as any uploaded supplemental information, to make a determination on the firm, individual or product they believe to be the most suitable and deserving winners for each category. The Judges’ Choice Awards are adjudicated by a panel of industry experts convened by the Fund Action and Fund Directions editorial teams. The industry judges contribute their sector expertise to debate the merits of shortlist candidates to come to a decision on the winners. (Award Page: mutualfundindustryawards.awardstage.com/)